Northrop Grumman showed strong sales and tremendous profits last quarter. The company's 1.5 book-to-bill ratio suggests growth will keep coming in the near term.
Northrop Grumman (NOC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is how Northrop Grumman (NOC) and RTX (RTX) have performed compared to their sector so far this year.
Northrop shares soared higher thanks to a strong second-quarter performance. The company also provided some much-needed clarity on its B-21 bomber contract.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Betting Big On Defense: Northrop Grumman Is Back
Northrop Grumman (NOC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, NOC crossed above the 200-day moving average, suggesting a long-term bullish trend.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 350 points on Thursday.
Northrop's (NOC) Q2 sales of $10.22 billion outpace the Zacks Consensus Estimate by 1.4%. The top line also rises 6.7% from the year-ago quarter's level.
The headline numbers for Northrop Grumman (NOC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Northrop Grumman (NOC) came out with quarterly earnings of $6.36 per share, beating the Zacks Consensus Estimate of $5.95 per share. This compares to earnings of $5.34 per share a year ago.
U.S. defense company Northrop Grumman raised its forecast for full-year revenue and profit on Thursday, amid increased global defense spending and a strong backlog.